SEC Form D · Amendment · filed December 1, 2016
Euclises Pharmaceuticals, Inc
Rule 506(c): private placement that may advertise publicly; all investors must be verified accredited.
People & firms on this filing (20)
Rick J. Ryan · St. Louis, MODirectorCharles A. Bolten · St. Louis, MODirectorRobert A. Beardsley · St. Louis, MODirectorRajesh J. Devraj · St. Louis, MODirectorRobert J. Calcaterra · St. Louis, MODirectorJohn J. Talley · St. Louis, MODirectorBobby W. Sandage, Jr · St. Louis, MOExec · DirectorRobert A. Beardsley · St. Louis, MODirectorRafael A. Labourdette · Rye Brook, NYExec · DirectorAfsaneh M. Beschloss · Washington, Washington, D.C.DirectorJohn Rourke · New York, NYDirectorJohn J. Talley · St. Louis, MODirectorScott D. Macdonald · Toronto, Ontario, CanadaDirectorElizabeth W. Cermak · San Ramon, CADirectorDiego D. De La Torre De La Piedra · Vancouver, British Columbia, CanadaDirectorEric Noble · Salt Lake City, UTDirectorClint Peterson · Salt Lake City, UTDirectorMatthew Day · Salt Lake City, UTDirectorRandy Fleischer · Dallas, TXExec · DirectorGrant Herlitz · Dallas, TXDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗